Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 2-Uncommon Sarcomas.
Levy AD, Manning MA, Miettinen MM.
Radiographics. 2017 May-Jun;37(3):797-812. doi: 10.1148/rg.2017160201.
Soft tissue limb and trunk sarcomas: diagnosis, treatment and follow-up.
Rastrelli M, Tropea S, Basso U, Roma A, Maruzzo M, Rossi CR.
Anticancer Res. 2014 Oct;34(10):5251-62.
Effect of negative pressure wound therapy after surgical removal of deep-seated high-malignant soft tissue sarcomas of the extremities and trunk wall-study protocol for a randomized controlled trial.
Yilmaz M, Thorn A, Sørensen MS, Jensen CL, Petersen MM.
Trials. 2022 Jun 18;23(1):507. doi: 10.1186/s13063-022-06468-6.
Soft tissue tumors in first year of life: a report of 190 cases.
Coffin CM, Dehner LP.
Pediatr Pathol. 1990;10(4):509-26. doi: 10.3109/15513819009067140.
Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.
Graham RP, Dry S, Li X, Binder S, Bahrami A, Raimondi SC, Dogan A, Chakraborty S, Souchek JJ, Folpe AL.
Am J Surg Pathol. 2011 Nov;35(11):1615-25. doi: 10.1097/PAS.0b013e3182284a3f.
Follow-up after initial surgical treatment of soft tissue sarcomas in the extremities and trunk wall.
Hovgaard TB, Nymark T, Skov O, Petersen MM.
Acta Oncol. 2017 Jul;56(7):1004-1012. doi: 10.1080/0284186X.2017.1299937. Epub 2017 Mar 13.
Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases.
Deyrup AT, Tighiouart M, Montag AG, Weiss SW.
Am J Surg Pathol. 2008 Jun;32(6):924-7. doi: 10.1097/pas.0b013e31815bf8e6.
Clinicopathological study of pseudomyogenic hemangioendothelioma.
Yang N, Huang Y, Yang P, Yan W, Zhang S, Li N, Feng Z.
Diagn Pathol. 2023 Feb 20;18(1):25. doi: 10.1186/s13000-023-01309-9.
Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC.
Oba A, Bao QR, Barnett CC, Al-Musawi MH, Croce C, Schulick RD, Del Chiaro M.
Scand J Surg. 2020 Mar;109(1):18-28. doi: 10.1177/1457496919900413. Epub 2020 Jan 21.
Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.
Youssef E, Fontanesi J, Mott M, Kraut M, Lucas D, Mekhael H, Ben-Josef E.
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):514-9. doi: 10.1016/s0360-3016(02)02942-5.
